George Syrmalis
Follow
Get notifications in MyBN when activity occurs.
George Syrmalis
Executive Chair, Chief Executive / IQ3CORP
Most Notable Role
Dr George Syrmalis is the executive chair and chief executive of The iQ Group Global. He founded the company in 2010 to converge investment banking, scientific discovery, corporate advisory and commercialisation, and to bring medical innovations to the world.
Between 1995 and 2005, he founded and led The Bionuclear Group SA as chief executive and chair, incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA and Vitalcheck SA.
Dr Syrmalis is a fellow of the American Academy of Pharmaceutical Physicians, the American College of Nuclear Physicians, the American College of Nuclear Medicine, and the New York Academy of Sciences.
Between 1995 and 2005, he founded and led The Bionuclear Group SA as chief executive and chair, incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA and Vitalcheck SA.
Dr Syrmalis is a fellow of the American Academy of Pharmaceutical Physicians, the American College of Nuclear Physicians, the American College of Nuclear Medicine, and the New York Academy of Sciences.
Lists and Charts
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 736th |  | Farmaforce | $14.7m |
| 861st | | Wellness and Beauty Solutions | $5.0m |
| 862nd |  | Adherium | $5.0m |
| 864th | | Chimeric Therapeutics | $4.9m |
| 865th | | Ironbark Capital | $4.9m |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Executive Chair, Chief Executive, IQ3CORP | 03 Nov 2020 |
| NEW ROLE: Group Chief Executive, Executive Director, Farmaforce | 03 Nov 2020 |
